Abstract
Firstly the chapter approaches risk management in a general sense, including the phases of risk assessment (risk identification, risk analysis and risk evaluation), risk control (risk reduction or mitigation, and risk acceptance), risk documentation and communication, and risk review. Then some methods for risk assessment are explored further, such as matrix type and Failure Mode Effect Analysis (FMEA) using risk priority numbers (RPN).
Quality risk management (QRM) is illustrated by practical examples about logistics, equipment, pharmaceutical care on the wards and clinical pharmacy.
QRM finds its way into medicines regulations as it is seen as a systematic process for the assessment, control, communication and review of risks to the quality of the medicinal product. A structured and documented management of risks is a requirement in EU GMP as well as in the European Pharmacopoeia (Ph. Eur.). A guideline with a description of QRM elements together with appropriate tools is to be found in ICH Q9, mainly directed at manufacturing. Finally implementation of QRM in the Pharmaceutical Quality System is briefly elaborated.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
European Commission. EudraLex—Volume 4. Good Manufacturing Practice (GMP) Guidelines. Part III, GMP related documents. Quality Risk Management (Q9 ICH), January 2011. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002873.pdf. Accessed August 2014
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Quality Risk Management ICH Q9 Briefing Pack. http://www.ich.org/products/guidelines/quality/q9-briefing-pack.html. Accessed August 2014
Ris JM, Van Leeuwen RWF, Boom FA (2010) VTGM op de ICU (“Parenteral admixtures on the ICU”): mind the steps! PW Wetenschappelijk Platform 4(1):11–17
Institute for Safe Medication Practices. ISMP list of high-alert medications in Acute Care Settings. http://www.ismp.org/Tools/highalertmedications.pdf. Accessed August 2014
Wunder C, Hein R, Idinger G (2013) Development of quality risk management in the clinical pharmacy field. Eur J Hosp Pharm 20:218–222. doi:10.1136/ejhpharm-2012-0002542
European Committee for standardization. EN15224 Health care services – Quality management systems – Requirements based on EN ISO 9001:2008. Annex B: Practical guide for the implementation of this standard in health care organizations.
Assessment of quality risk management implementation. PIC/S aide-memoire. PI 038–1. March 2012. http://www.picscheme.org. Accessed December 2013
WHO guidelines on quality risk management. Annex 2, in: WHO Technical Report Series No. 981, 2013: 73–4. http://www.who.int/medicines/areas/quality_safety/quality_assurance/Annex2TRS-981.pdf. Accessed August 2014
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 KNMP and Springer International Publishing Switzerland
About this chapter
Cite this chapter
Bouwman-Boer, Y., Møller Andersen, L. (2015). Quality Risk Management. In: Bouwman-Boer, Y., Fenton-May, V., Le Brun, P. (eds) Practical Pharmaceutics. Springer, Cham. https://doi.org/10.1007/978-3-319-15814-3_21
Download citation
DOI: https://doi.org/10.1007/978-3-319-15814-3_21
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-15813-6
Online ISBN: 978-3-319-15814-3
eBook Packages: MedicineMedicine (R0)